ANN NARCOONIS: Open Payments
NPI 1578938056 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$156 in 8 payments from 7 companies in 2025. Trend: 2023 $67 · 2024 $335 · 2025 $156
Food & beverage: $156
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $34 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Alkermes, Inc. | 1 | $23 |
| Braeburn Inc. | 1 | $19 |
| Almatica Pharma LLC | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: REXULTI, COBENFY, ARISTADA, BRIXADI, LOREEV XR, INVEGA SUSTENNA, Qelbree.
Industry payments across PA — which companies pay providers there.
